Utilization of an aspiration thrombectomy catheter (Pronto) to treat acute atherothrombotic embolization during percutaneous revascularization of the lower extremity

Zafar, Nayab; Prasad, Anand; Mahmud, Ehtisham

doi:10.1002/ccd.21561

Cited by 12 publications

(8 citation statements)

References 49 publications

(63 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In myocardial infarction, aspiration of the thrombus and cleaning of atherosclerosis material before stent implantation has improved blood flow in arterioles and capillaries [35]. There are studies that show PT administration in ALI is effective [36]. However, distal microembolization and dissection are disadvantages of PT use [14].…”

Section: Discussionmentioning

confidence: 99%

“…AHA and ESC have recommended tirofiban use in patients with massive thrombus, no-flow, slow flow, and thrombolytic complications for ST segment elevation myocardial infarction [44,45]. Tirofiban is effective in peripheral arterial disease with massive thrombus load, and using ALI with tpA has been shown to be effective and safe [19,36]. Decreased distal microembolization, platelet aggregation, and vascular thrombus formation potentially decreased abrupt PPI closure have increased the efficacy of thrombolytic therapy and improved long-term revascularization rates, with a potential decreased need for secondary re-interventions, especially in the diabetic ALI population [19,20].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Early Thrombosuction and Tirofiban Use in Knee and Below-Knee Arterial Thrombosis

et al. 2017

View full text Add to dashboard Cite

BackgroundAcute limb ischemia (ALI) is a clinical entity with a high rate of morbidity and mortality. Despite advances and variety of its management, there is still no criterion standard treatment. The goal of this study was to evaluate the effect of tirofiban use on the early and 6-month prognosis of patients with knee and below-knee arterial thrombosis who were treated with percutaneous thrombosuction (PT) within 24 h.Material/MethodsData of consecutive ALI patients who were diagnosed with popliteal and infra-popliteal arterial thrombosis and underwent PT procedure within 24 h between January 2010 and September 2015 were evaluated retrospectively. Patients were separated into 2 groups according to tirofiban usage.ResultsA total of 105 patients (mean age 67±16; 53% men) were included in the study. Atrial fibrillation (n 64, 61%) and hypertension (n 60, 57%) were the most frequent comorbidities in patients with thromboembolic events. A significantly higher rate of distal embolization (6% vs. 16%; p=0.01) and slow-flow (17% vs. 30%; p<0.01) developed in patients who were not treated with tirofiban after the PT procedure. Although major and minor bleeding were more frequent in the tirofiban group, only the rate minor bleeding was statistically significant (29% vs. 9%, p=0.001). Reverse embolic event ratio was similar in both groups. Although there was a higher rate of amputation in patients not treated with tirofiban, the difference was not significant.ConclusionsAdding tirofiban to PT reduces angiographic thromboembolic complications. Usage of tirofiban in patients prone to thromboembolic events may be useful for improving success of the PT procedure, with a reasonable bleeding ratio.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Early Thrombosuction and Tirofiban Use in Knee and Below-Knee Arterial Thrombosis

et al. 2017

View full text Add to dashboard Cite

show abstract

“…It has been used successfully in management of acute stent thrombosis 9. There are a few case reports of utilizing Pronto V3 in managing non-coronary vascular thrombosis 10–12. Ours is the first documented case utilizing Pronto V3 thrombectomy device in managing acute superficial femoral artery thrombosis.…”

Section: Discussionmentioning

confidence: 99%

Acute Complication Due to Impella 2.5 Device (Superficial Femoral Artery Thrombosis): Managed Successfully with Novel Aspiration Thrombectomy catheter (pronto V3)

Bhat

Waked

Teli

et al. 2011

Clin Med Insights Cardiol

View full text Add to dashboard Cite

The Impella recover LP 2.5 is a percutaneous left ventricular assist device (LVAD) recently approved for use in patients undergoing high risk percutaneous coronary intervention (PCI) and also in cases of cardiogenic shock. There is limited evidence available in literature about its safety, especially with regards to the incidence of local vascular complications, their management and long-term implications. We report here the first case of a serious local vascular complication—superficial femoral artery thrombus formation during Impella recover LP 2.5 use in a high risk PCI which was managed successfully with novel aspiration thrombectomy catheter (Pronto V3), which in itself is the first reported use of Pronto V3 in such a vascular complication.

show abstract

“…This technique involves using large lumen aspiration catheters attached to suction with a syringe to remove [10]. The Penumbra System (PS; Penumbra, Alameda, California) offers the ability to both aspirate and extract material, Figure 2.…”

Section: Percutaneous Aspiration Thrombectomy (Pat)mentioning

confidence: 99%

Acute lower limb ischaemia

et al. 2017

View full text Add to dashboard Cite

Utilization of an aspiration thrombectomy catheter (Pronto) to treat acute atherothrombotic embolization during percutaneous revascularization of the lower extremity

Cited by 12 publications

References 49 publications

Early Thrombosuction and Tirofiban Use in Knee and Below-Knee Arterial Thrombosis

Early Thrombosuction and Tirofiban Use in Knee and Below-Knee Arterial Thrombosis

Acute Complication Due to Impella 2.5 Device (Superficial Femoral Artery Thrombosis): Managed Successfully with Novel Aspiration Thrombectomy catheter (pronto V3)

Acute lower limb ischaemia

Contact Info

Product

Resources

About